Dr. Andrew H Ko, MD
Claim this profileUniversity of California San Francisco
Studies Pancreatic Cancer
Studies Adenocarcinoma
9 reported clinical trials
23 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
BRCA1 positive
2Adenocarcinoma
Stage IV
PD-L1 positive
PD-L1 negative
Affiliated Hospitals
Clinical Trials Andrew H Ko, MD is currently running
Avutometinib + Defactinib + Chemotherapy
for Pancreatic Cancer
This trial tests a new treatment combining two experimental drugs with two existing treatments for patients with newly diagnosed pancreatic cancer. The goal is to see if this combination can safely and effectively stop cancer growth and kill cancer cells. The study focuses on patients who have not yet received any treatment. One of the existing treatments used in the trial has been important in pancreatic cancer treatment but offers only modest improvements in symptoms and survival.
Recruiting1 award Phase 1 & 27 criteria
Trametinib + Hydroxychloroquine
for Pancreatic Cancer
This phase I trial studies the sides effects and best dose of hydroxychloroquine when given together with trametinib in treating patients with pancreatic cancer that has spread to nearby tissue, lymph nodes or other places in the body and cannot be removed by surgery. Trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as hydroxychloroquine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving trametinib together with hydroxychloroquine may work better in treating patients with pancreatic cancer.
Recruiting1 award Phase 116 criteria
More about Andrew H Ko, MD
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Andrew H Ko, MD has experience with
- Gemcitabine
- Fluorouracil
- Leucovorin Calcium
- Oxaliplatin
- Capecitabine
- Hydroxychloroquine
Breakdown of trials Andrew H Ko, MD has run
Pancreatic Cancer
Adenocarcinoma
Cancer
Adenosquamous Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew H Ko, MD specialize in?
Andrew H Ko, MD focuses on Pancreatic Cancer and Adenocarcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Andrew H Ko, MD currently recruiting for clinical trials?
Yes, Andrew H Ko, MD is currently recruiting for 6 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Andrew H Ko, MD has studied deeply?
Yes, Andrew H Ko, MD has studied treatments such as Gemcitabine, Fluorouracil, Leucovorin Calcium.
What is the best way to schedule an appointment with Andrew H Ko, MD?
Apply for one of the trials that Andrew H Ko, MD is conducting.
What is the office address of Andrew H Ko, MD?
The office of Andrew H Ko, MD is located at: University of California San Francisco, San Francisco, California 94158 United States. This is the address for their practice at the University of California San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.